Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Energy drinks tested for alertness boost – but Don't get too excited

NCT ID NCT07400614

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 4 times

Summary

This study looks at whether energy drinks with 120 mg of caffeine, plus taurine and B vitamins, can help healthy adults feel more alert for up to 5 hours. 48 participants will rate their alertness and tiredness after drinking the beverages. The goal is to see if the added ingredients make a difference compared to caffeine alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Caffeine with varying amounts of taurine and B vitamins
What this could lead to
If it works, this could show that certain energy drink formulas boost alertness for a few hours.
What could go wrong
This is a small, early-stage study with only 48 people, so results may not apply to everyone. It only measures subjective feelings, not long-term health effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

48 people

The number who actually took part.

Started

Jan 2026

Finished

Jun 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 49 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants are aged 18-49 years, inclusive * Participants self-report that they are in good health * Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial * Willing to abstain from consumption of caffeine for 12 h prior to testing * Willing to abstain from alcohol consumption and avoid vigorous physical activity for 24 h prior to all test visits * Willing to refrain from 'over the counter' medications (e.g. pain medication) and stimulant medication for 12 hours, seasonal allergy/hayfever nasal antihistamine medications for 24 hours and oral antihistamines for 48 hours prior to all test visits * Regular caffeine consumer (at least one caffeinated beverage per day, not less than 35 mg) * Are fluent in English (equivalent to IELTS Level 6) * Understand the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study Investigator Exclusion Criteria: * Fail to meet any one of the inclusion criteria * Currently use of prescription medication, including contraceptives * Report hypersensitivity to caffeine * Have experienced major trauma or major surgical event within 6 months of screening * Have extreme dietary habits, as judged by the Investigator (high fat, very high protein diets, intermittent fasting, etc.) * Have a history of cancer in the prior two years, except for non-melanoma skin cancer * Have a visual impairment that cannot be corrected with glasses or contact lenses * Have food allergies/intolerances/sensitivities to any ingredients in the study products (including coffee or related foods/beverages/products) * Self-report excessive leisure time physical activity (\> 7 strenuous bouts per week) * Have current or chronic gastrointestinal, sleep, or psychiatric disorders * Work night shifts or follow a variable work pattern that results in irregular sleep pattern * Are pregnant, trying to get pregnant or lactating * Smoke tobacco, vape nicotine or use nicotine replacement products * Use illegal/recreational drugs * Are unable to demonstrate adequate minimal performance on lab, computer-based cognitive tasks * Have high blood pressure (systolic over 139 mm Hg or diastolic over 89 mm Hg) * Have a Body Mass Index (BMI) outside of the range 18.5-35 kg/m2 (unless waist to hip ratio is less than or equal to 0.85 (female) or 0.90 (male)) * Have been diagnosed with a neurological condition, or assessed as having a learning/behavioural or neurodevelopmental difference (e.g. dyslexia, autism, ADHD) * Consume excessive caffeine intake (\>400 mg per day) * Have taken any dietary supplements e.g. Vitamins, omega 3 fish oils etc. in the last 4 weeks (Note: participation is possible following a 4 week supplement washout prior to participating and for the duration of the study on the proviso that the supplements they are taking are out of choice and not medically prescribed or advised) * Have any health condition that would prevent fulfilment of the study requirements (this includes non-diagnosed conditions for which no medication may be taken) * Have been diagnosed with/ undergoing treatment for alcohol or drug abuse in the last 12 months * Have been diagnosed with/ undergoing treatment for a psychiatric disorder in the last 12 months * Suffer from frequent migraines that require medication (more than or equal to 1 per month) * Have any known active infections * Do not have a bank account (required for payment) * Have participated in another clinical trial within past 30 days and/or participation in another PepsiCo trial in the past 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alertness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Northumbria U

    Newcastle, Tyne, NE1 7RU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.